BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11063424)

  • 1. Preparation and in vitro characterization of gelatin microspheres containing Levodopa for nasal administration.
    Brime B; Ballesteros MP; Frutos P
    J Microencapsul; 2000; 17(6):777-84. PubMed ID: 11063424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.
    Choudhary H; Agrawal AK; Malviya R; Yadav SK; Jaliwala YA; Patil UK
    Pharmazie; 2010 Mar; 65(3):194-8. PubMed ID: 20383939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique.
    Ugwoke MI; Kinget R
    J Microencapsul; 1998; 15(3):273-81. PubMed ID: 9608392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa delivery systems: advancements in delivery of the gold standard.
    Ngwuluka N; Pillay V; Du Toit LC; Ndesendo V; Choonara Y; Modi G; Naidoo D
    Expert Opin Drug Deliv; 2010 Feb; 7(2):203-24. PubMed ID: 20095943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellulose acetate microspheres prepared by o/w emulsification and solvent evaporation method.
    Soppimath KS; Kulkarni AR; Aminabhavi TM; Bhaskar C
    J Microencapsul; 2001; 18(6):811-7. PubMed ID: 11695643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of lipospheres as carriers for bioactive compounds.
    Cortesi R; Esposjto E; Luca G; Nastruzzi C
    Biomaterials; 2002 Jun; 23(11):2283-94. PubMed ID: 12013175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin-loaded bovine serum albumin microspheres: preparation and drug-release in vitro.
    Li FQ; Hu JH; Lu B; Yao H; Zhang WG
    J Microencapsul; 2001; 18(6):825-9. PubMed ID: 11695645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
    Sharma S; Lohan S; Murthy RS
    Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
    Preda M; Leucuta SE
    J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of microsphere solidification time in the solvent evaporation process.
    Mateović T; Ratnik M; Bogataj M; Mrhar A
    J Microencapsul; 2005 Feb; 22(1):81-90. PubMed ID: 16019893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of poly(butylene succinate) microspheres for delivery of levodopa in the treatment of Parkinson's disease.
    Mohanraj K; Sethuraman S; Krishnan UM
    J Biomed Mater Res B Appl Biomater; 2013 Jul; 101(5):840-7. PubMed ID: 23401377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of levodopa methyl ester intranasal delivery systems.
    Chun IK; Lee YH; Lee KE; Gwak HS
    J Parkinsons Dis; 2011; 1(1):101-7. PubMed ID: 23939261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.
    Kao HD; Traboulsi A; Itoh S; Dittert L; Hussain A
    Pharm Res; 2000 Aug; 17(8):978-84. PubMed ID: 11028945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
    Muvaffak A; Gurhan I; Gunduz U; Hasirci N
    J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
    Sheshala R; Peh KK; Darwis Y
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of emulsifier blend on the characteristics of sustained release diclofenac microspheres.
    Lewis L; Boni R; Adeyeye CM
    J Microencapsul; 1998; 15(3):283-98. PubMed ID: 9608393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide.
    Haznedar S; Dortunç B
    Int J Pharm; 2004 Jan; 269(1):131-40. PubMed ID: 14698584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of sustained-release propranolol wax microspheres.
    Varshosaz J; Keihanfar M
    J Microencapsul; 2001; 18(3):277-84. PubMed ID: 11308219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.